Nuvation Bio Inc (NUVB) has fallen Tuesday morning, with the stock losing -3.13% in pre-market trading to 1.24. NUVB's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, NUVB ranks higher than 55% of stocks. Nuvation Bio Inc has risen 9.40% over the past month, closing at $1.20 on October 17. During this period of time, the stock fell as low as $0.96 and as high as $1.38. NUVB has an average analyst recommendation of Strong Buy. The company has an average price target of $3.98.
NUVB has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on NUVB!